http://purl.org/np/RAUUK3nf5Y... RAUUK3nf5Y

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom

https://dailymed.nlm.nih.gov/d...51-2743-4755-8398-fed5402283f6 drugInfo.cfm?setid=a310fc51-2743-4755-8398-fed5402283f6

Leoni Bücken

2021-04-03T09:37:19.256Z

http://purl.org/np/RAUUK3nf5Y... RAUUK3nf5Y

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/ns/prov#value value

Vyvanse® is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

Leoni Bücken

2021-04-03T09:37:19.256Z

http://purl.org/np/RAUUK3nf5Y... RAUUK3nf5Y

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://purl.org/np/RAUUK3nf5Y...#medtherapy medtherapy

http://www.w3.org/ns/prov#wasDerivedFrom wasDerivedFrom

Leoni Bücken

2021-04-03T09:37:19.256Z